Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease.

Item

http://www.wikidata.org/entity/Q37313167

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Low opsonic activity to the in ...... invasive pneumococcal disease.

@en

Low opsonic activity to the in ...... invasive pneumococcal disease.

@nl

type

Item

label

Low opsonic activity to the in ...... invasive pneumococcal disease.

@en

Low opsonic activity to the in ...... invasive pneumococcal disease.

@nl

prefLabel

Low opsonic activity to the in ...... invasive pneumococcal disease.

@en

Low opsonic activity to the in ...... invasive pneumococcal disease.

@nl

P1476

Low opsonic activity to the in ...... invasive pneumococcal disease

@en

P2093

Bin Chang

http://www.w3.org/2001/XMLSchema#string

Japanese IPD Study Group

http://www.w3.org/2001/XMLSchema#string

Junichiro Nishi

http://www.w3.org/2001/XMLSchema#string

Kazunori Oishi

http://www.w3.org/2001/XMLSchema#string

Kazuyo Tamura

http://www.w3.org/2001/XMLSchema#string

Kousaku Matsubara

http://www.w3.org/2001/XMLSchema#string

Naruhiko Ishiwada

http://www.w3.org/2001/XMLSchema#string

Tomohiro Oishi

http://www.w3.org/2001/XMLSchema#string

Toshiaki Ihara

http://www.w3.org/2001/XMLSchema#string

Yukihiro Akeda

http://www.w3.org/2001/XMLSchema#string

P2860

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia.

Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.

Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.

Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption.

Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies.

Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera.

P304

845-849

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2012.11.010

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Moon H. Nahm

P577

2012-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233422628

http://www.w3.org/2001/XMLSchema#string

P698

23153440

http://www.w3.org/2001/XMLSchema#string

P932

3829722

http://www.w3.org/2001/XMLSchema#string